# Ethnic Differences in Mechanisms of Action of Dupilumab

> **NCT05268107** · PHASE4 · RECRUITING · sponsor: **University of Michigan** · enrollment: 30 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT05268107
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-25
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05268107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05268107, "Ethnic Differences in Mechanisms of Action of Dupilumab". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05268107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*